Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY) shares, reducing it to $973.00 from the previous $995 ...

The S&P 500 jumped 1% on Friday, Jan. 17, 2025, heading into the long weekend on a high note as prospects rebounded for ...

Guggenheim lowered the firm’s price target on Eli Lilly (LLY) to $973 from $995 and keeps a Buy rating on the shares. The firm is updating its ...

Schlumberger reported better-than-expected Q4 2024 results, with revenue up 3%, EPS up 7%, and a 3% dividend increase.

Keefe Bruyette analyst Jade Rahmani lowered the firm’s price target on KB Home (KBH) to $76 from $85 and keeps a Market Perform rating on the ...

Truist lowered the firm’s price target on United Rentals (URI) to $963 from $965 and keeps a Buy rating on the shares as part ...

In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...

In the third quarter of 2024, sustainable open-end and exchange-traded funds witnessed a surge in net new money, drawing in an estimated USD 10.4 billion. This represents a significant increase ...

LG H&H Co. Ltd. 0.33% ₩4.71T LG H&H Co. Ltd. Pfd. Series 1-0.77% ₩4.71T ...